highly significantP < 0.001
The high-risk group exhibited a strikingly higher 30-day mortality rate of 28.0% as opposed to the 1.7% in the low-risk group, with a highly significant difference ( P < 0.001).
The high-risk group exhibited a strikingly higher 30-day mortality rate of 28.0% as opposed to the 1.7% in the low-risk group, with a highly significant difference ( P < 0.001).
Hypoproteinemia showed a trend toward increased mortality (11.97% vs 3.38%, HR 1.802, P = 0.056).